Menu Close
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech
An Official Publication of
  • Clinical
    • In the Literature
    • Key Clinical Questions
    • Interpreting Diagnostic Tests
    • Coding Corner
    • Clinical
    • Clinical Guidelines
    • COVID-19
    • POCUS
  • Practice Management
    • Quality
    • Public Policy
    • How We Did It
    • Key Operational Question
    • Technology
    • Practice Management
  • Diversity
  • Career
    • Leadership
    • Education
    • Movers and Shakers
    • Career
    • Learning Portal
    • The Hospital Leader Blog
  • Pediatrics
  • HM Voices
    • Commentary
    • In Your Eyes
    • In Your Words
    • The Flipside
  • SHM Resources
    • Society of Hospital Medicine
    • Journal of Hospital Medicine
    • SHM Career Center
    • SHM Converge
    • Join SHM
    • Converge Coverage
    • SIG Spotlight
    • Chapter Spotlight
    • From JHM
  • Industry Content
    • Patient Monitoring with Tech

Diabetes

  • 1
    News

    Real-world data show SGLT2 inhibitors for diabetes triple DKA risk

    July 29, 2020

    The findings are based on the use of three different SGLT2 inhibitors in Canada and the United Kingdom.

  • 1
    News

    Cleaner data confirm severe COVID-19 link to diabetes, hypertension

    July 27, 2020

    Initial reports that tied more severe COVID-19 disease to diabetes or hypertension used confounded data, but more refined data show similar links.

  • News

    Guidance addresses elders with diabetes during COVID-19

    July 16, 2020

    Two geriatricians from the Joslin Diabetes Center offer advice for navigating the challenges associated with helping these vulnerable adults during the COVID-19 pandemic.

  • News

    Hyperglycemia predicts COVID-19 death even without diabetes

    July 13, 2020

    This finding came from a retrospective analysis of 605 patients with COVID-19 seen at two hospitals in Wuhan, China.

  • News

    Delayed diagnoses seen in children during COVID-19

    July 9, 2020

    "Pediatricians on the frontline know what to expect with diabetes. Those children who would have come in late prior to the pandemic are now arriving very late."

  • News

    Captopril questioned for diabetes patients in COVID-19 setting

    July 2, 2020

    Captopril appears to be associated with a higher rate of pulmonary adverse reactions in patients with diabetes than that of other ACE inhibitors or angiotensin receptor blockers, a new study suggests.

  • 1
    News

    Dapagliflozin benefits low-EF heart failure regardless of diuretic dose: DAPA-HF

    June 26, 2020

    The trial that turned an SGLT2 inhibitor into a heart failure drug also has clues to mechanisms behind the observed benefits. Contrary to early speculation, diuresis may be off the list.

  • 1
    News

    ED visits for life-threatening conditions declined early in COVID-19 pandemic

    June 23, 2020

    Visits for MI, stroke, and hypoglycemic crisis dropped 10%-23% over the first 10 weeks.

  • 1
    News

    Cost of preventable adult hospital stays topped $33 billion in 2017

    June 23, 2020

    Heart failure, diabetes, and COPD were the most expensive preventable conditions.

  • News

    Where does dexamethasone fit in with diabetic ketoacidosis in COVID-19?

    June 22, 2020

    Author of new article discussing considerations around diabetic ketoacidosis in the setting of COVID-19 also speaks to the findings this week that dexamethasone could reduce deaths in the severely ill.

Previous1 … 5 6 7 8 9 … 14Next
  • About The Hospitalist
  • Contact Us
  • The Editors
  • Editorial Board
  • Authors
  • Publishing Opportunities
  • Subscribe
  • Advertise
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies.
    ISSN 1553-085X
  • Privacy Policy
  • Terms and Conditions
  • SHM’s DE&I Statement
  • Cookie Preferences